Cellular Ex Vivo Lung Perfusion Beyond 1 Hour May Improve Marginal Donor Lung Assessment.

导出 LinkOut

翻译打印收藏纠错

第一作者： Hiromichi,Niikawa

第一单位： Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio; Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio.

作者： Hiromichi,Niikawa ^[1] ; Toshihiro,Okamoto ^[2] ; Kamal S,Ayyat ^[3] ; Yoshifumi,Itoda ^[1] ; Ichiro,Sakanoue ^[1] ; Carol F,Farver ^[4] ; James J,Yun ^[5] ; Kenneth R,McCurry ^[6]

作者单位： Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio; Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio. ^[1] Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio; Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio; Department of Transplant Center, Cleveland Clinic, Cleveland, Ohio. ^[2] Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio; Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio; Department of Cardiothoracic Surgery, Faculty of Medicine, Zagazig University, Zagazig, Egypt. ^[3] Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio. ^[4] Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio; Department of Transplant Center, Cleveland Clinic, Cleveland, Ohio. ^[5] Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio; Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio; Department of Transplant Center, Cleveland Clinic, Cleveland, Ohio. Electronic address: mccurrk@ccf.org. ^[6]

关键词 Human donor lungs Ischemia reperfusion injury Lund protocol Perfusion time Transplant suitability lung transplantation